Close Menu

Stanford

"What we're going to need to fully take advantage of Watson is to have the genetic and epigenetic information of patients so that the Watson program will be able to utilize and organize that also in medical decision making," said a researcher involved with IBM's efforts to develop an artificial intelligence system that can help doctors diagnose patients accurately and quickly.

The case before the Supreme Court poses questions about the federal funding IP law.

Stanford University, Life Technologies, Becton Dickinson, and Gen-Probe win US patents.

Eppendorf, Gen-Probe, Kaohsiung Medical University, Stanford University, and Life Technologies are awarded US patents.

A bioethicist argues that it is now time to start taking steps to consider how to handle ethical, social, and legal issues that loom over non-invasive prenatal genetic tests.

After lengthy deliberations, the Tufts faculty decided that students for the time being would benefit from using anonymous genomes instead of their own data to explore societal, policy, and ethical issues related to personalized whole-genome testing.

IP Roundup: Jan 25, 2011

Premium

Yale University, University of South Florida, Alabama State University, Stanford University, SRU Biosystems, Eppendorf Array Technology, Agilent Technologies, Acea Biosciences

Some players in the field cautioned that the industry may be too focused on lipid delivery, potentially passing over other technologies that, while at an earlier stage of development, may ultimately be successful for certain indications.

The amount of activity last year on the regulatory, reimbursement, legislative, educational, and intellectual property fronts is a sign that the wheels are slowly shifting toward creating a framework that will someday support and deliver genomically guided medicine, even though plenty of barriers and challenges need to be overcome on the path to that goal.

Despite advances, there remains much work to be done on the basic biology side of things if RNAi is ever to achieve its promise as a therapeutic modality, industry watchers said.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.